Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational "LORENA" study.

Onco Targets Ther · 2018 · PMC6149976 · PMID 30271167

Europe PMC DOI

hedged sentences

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

near-significantP =0.055so close (0.05 < p ≤ 0.1)

Two variables showed near-significant negative influence: diagnosis of triple-negative breast cancer ( P =0.055) and prior radiotherapy ( P =0.055).

also in 2,306 other papers

near significanceno p-value reported

Multivariate analysis of prognostic factors for OS included all variables that demonstrated statistical significance or near significance in the univariate analysis.

also in 505 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.